Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

计划入组 553 人 · 首次发布于 2022 年 12 月 29 日

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

计划入组 278 人 · 首次发布于 2006 年 12 月 8 日

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

计划入组 381 人 · 首次发布于 2008 年 12 月 5 日

Grass pollen allergy immunotherapy (Stallergenes Greer)

Birch pollen allergy vaccine(ALK-Abello)

SLIT-tablet

Liquid O2 Transfills, Inc.

United States

GILMORE LIQUID AIR CO.

United States

SCHWARCZ LIQUID NITROGEN SERVICE, INC.

United States

Stallergenes Greer to Present Paediatric Phase III YOBI Data and Real-World EfficAPSI Findings at EAACI 2026

ALK's House Dust Mite SLIT-Tablet Phase 3 Trial Results Published in The Lancet Regional Health – Europe

SCIT Demonstrates Superior IgG4 and Treg Induction Versus SLIT in House Dust Mite Allergy, Study Finds